Regardless of the negative posts above, the market 'liked' the results with the share price up 5% so far.
My interpretation is that the market sees the results as implying there is now zero probability of any further dilutive capital raises, and that this half year represents bottom of the cycle earnings, from which future earnings will start to rise.
- Forums
- ASX - By Stock
- Ann: H1 FY24 Results Presentation
Regardless of the negative posts above, the market 'liked' the...
Featured News
Add SGR (ASX) to my watchlist
(20min delay)
|
|||||
Last
21.0¢ |
Change
-0.005(2.33%) |
Mkt cap ! $602.4M |
Open | High | Low | Value | Volume |
22.0¢ | 22.0¢ | 20.5¢ | $3.435M | 16.21M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 461832 | 21.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.5¢ | 2611095 | 21 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 313997 | 0.210 |
97 | 5655835 | 0.205 |
184 | 9823106 | 0.200 |
34 | 2649245 | 0.195 |
44 | 1192110 | 0.190 |
Price($) | Vol. | No. |
---|---|---|
0.215 | 1388496 | 16 |
0.220 | 1216369 | 19 |
0.225 | 1480159 | 20 |
0.230 | 1402620 | 23 |
0.235 | 1906899 | 17 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
SGR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online